Mark Weatherall

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Ulcerative Colitis

Chronic Obstructive Pulmonary Disease

Top Venues

The European respiratory journal

Postgraduate medical journal

American journal of respiratory and critical care medicine

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Richard Beasley, Jonathan Noble, Mark Weatherall
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma. The European respiratory journal 63 (6) (2024)
Richard Beasley, Jonathan Noble, Mark Weatherall
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma. The European respiratory journal 63 (6) (2024)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Philip D Welsby, Mark Weatherall
Surveys are not simple: beware of the pitfalls. Postgraduate medical journal (2023)
Philip D Welsby, Mark Weatherall
Statistics: an introduction to basic principles. Postgraduate medical journal 98 (1164) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Richard Beasley, Jonathan Noble, Mark Weatherall
Clinical remission with biologic therapies in severe asthma: a matter of definition. The European respiratory journal 62 (6) (2023)
Philip D Welsby, Mark Weatherall
Surveys are not simple: beware of the pitfalls. Postgraduate medical journal 99 (1172) (2023)
Lynsey Sutton, Elliot Bell, Susanna Every-Palmer, Mark Weatherall, Paul M Skirrow
Survivorship of Patients After Long Intensive Care Stay With Exploration and Experience in a New Zealand Cohort (SPLIT ENZ): Protocol for a Mixed Methods Study. JMIR research protocols 11 (3) (2022)
Lynsey Sutton, Elliot Bell, Susanna Every-Palmer, Mark Weatherall, Paul M Skirrow
Correction: Survivorship of Patients After Long Intensive Care Stay With Exploration and Experience in a New Zealand Cohort (SPLIT ENZ): Protocol for a Mixed Methods Study. JMIR research protocols 11 (4) (2022)
Richard Beasley, Pepa Bruce, Lee Hatter, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Ian Douglas Pavord
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma. American journal of respiratory and critical care medicine 204 (1) (2021)
Philip D Welsby, Mark Weatherall
Surveys are not simple: beware of the pitfalls. Postgraduate medical journal (2021)
Philip D Welsby, Mark Weatherall
Statistics: an introduction to basic principles. Postgraduate medical journal (2021)
James Harper, Nethmi Kearns, Grace Bird, Robert McLachlan, Allie Eathorne, Mark Weatherall, Richard Beasley
Audit of oxygen administration to achieve a target oxygen saturation range in acutely unwell medical patients. Postgraduate medical journal (2021)
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ open research 7 (1) (2021)
Richard Beasley, James Harper, Grace Bird, Ingrid Maijers, Mark Weatherall, Ian Douglas Pavord
Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. American journal of respiratory and critical care medicine 199 (12) (2020)
Richard Beasley, James Harper, Grace Bird, Ingrid Maijers, Mark Weatherall, Ian Douglas Pavord
Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma. American journal of respiratory and critical care medicine 200 (12) (2020)
Richard Beasley, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Tim W Harrison, Alberto Papi, Ian Douglas Pavord
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma. The European respiratory journal 55 (1) (2020)
Richard Beasley, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Ian Douglas Pavord
Optimal Asthma Control: Time for a New Target. American journal of respiratory and critical care medicine 201 (12) (2020)
Christina Baggott, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Daniela Hall, Alexandra Vohlidkova, Robert J Hancox, Mark Weatherall, James Fingleton, Richard Beasley, null null
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial. The European respiratory journal 56 (4) (2020)
Christina Baggott, Paul Hansen, Robert J Hancox, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Mark Weatherall, Richard Beasley, Helen K Reddel, James Fingleton, null null
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment. Thorax 75 (10) (2020)
Richard Beasley, Grace Bird, James Harper, Mark Weatherall
Asthma paradoxes: time for a new approach across the spectrum of asthma severity. The European respiratory journal 53 (4) (2019)
Duncan Smyth, Stuart Mossman, Mark Weatherall, Evan Jolliffe, Purwa Joshi, Jennifer Taylor, Katie Thorne, Eloise Watson, Ruth Leadbetter, Benjamin Mossman, Tawhai Moss, Nicholas Todd, Erich Schneider
Gentamicin vestibulotoxicity with modern systemic dosing regimens: a prospective study using video-oculography. Acta oto-laryngologica 139 (9) (2019)
Richard Beasley, Grace Bird, James Harper, Mark Weatherall
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity. The European respiratory journal 52 (5) (2018)
Richard Beasley, Irene Braithwaite, James Fingleton, Mark Weatherall
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here? The European respiratory journal 51 (1) (2018)
George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. BMC pulmonary medicine 18 (1) (2018)